Apellis Pharmaceuticals, Inc. (APLS)

25.20 -0.11 (-0.43%) USD  |  NASDAQ  |  Dec 17, 16:00
25.11 -0.09 (-0.36%) After-Hours: 20:00
More

Apellis Pharmaceuticals Total Operating Expenses (TTM)

Total Operating Expenses (TTM) Chart

View Total Operating Expenses (TTM) for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (TTM) Range, Past 5 Years

View Total Operating Expenses (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (TTM) Benchmarks

View Total Operating Expenses (TTM) Benchmarks
Start Trial
Biogen, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
Ultragenyx Pharmaceutical, Inc. Upgrade
Fulcrum Therapeutics, Inc. Upgrade